These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28881668)
1. The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma. Zhu J; Liang C; Hua Y; Miao C; Zhang J; Xu A; Zhao K; Liu S; Tian Y; Dong H; Zhang C; Li P; Su S; Qin C; Wang Z Oncotarget; 2017 Aug; 8(31):51559-51568. PubMed ID: 28881668 [TBL] [Abstract][Full Text] [Related]
2. CD151 promotes cell metastasis via activating TGF-β1/Smad signaling in renal cell carcinoma. Yu Y; Liang C; Wang S; Zhu J; Miao C; Hua Y; Bao M; Cao Q; Qin C; Shao P; Wang Z Oncotarget; 2018 Mar; 9(17):13313-13323. PubMed ID: 29568359 [TBL] [Abstract][Full Text] [Related]
3. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1. Zeng TD; Zheng B; Zheng W; Chen C Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774 [TBL] [Abstract][Full Text] [Related]
4. The metastasis suppressor CD82/KAI1 represses the TGF-β Lee MS; Lee J; Kim YM; Lee H Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375 [TBL] [Abstract][Full Text] [Related]
5. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation. Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075 [TBL] [Abstract][Full Text] [Related]
6. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Zhou B; Liu L; Reddivari M; Zhang XA Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270 [TBL] [Abstract][Full Text] [Related]
7. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells. Jee BK; Lee JY; Lim Y; Lee KH; Jo YH Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548 [TBL] [Abstract][Full Text] [Related]
8. KAI1/CD82, a tumor metastasis suppressor. Liu WM; Zhang XA Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083 [TBL] [Abstract][Full Text] [Related]
9. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition. Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma. Liu Y; Qian J; Li X; Chen W; Xu A; Zhao K; Hua Y; Huang Z; Zhang J; Liang C; Su S; Li P; Shao P; Li J; Qin C; Wang Z Oncotarget; 2016 Dec; 7(49):81410-81422. PubMed ID: 27806310 [TBL] [Abstract][Full Text] [Related]
11. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration. Zhang XA; He B; Zhou B; Liu L J Biol Chem; 2003 Jul; 278(29):27319-28. PubMed ID: 12738793 [TBL] [Abstract][Full Text] [Related]
12. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295 [TBL] [Abstract][Full Text] [Related]
13. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma. Prabhu VV; Devaraj SN J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma. Wang G; Jiang H; Xu H; Sun Q; Zhou Y; Xiang P; Cheng Z; Zhang Y; Zhou Y; Guo Q; DU X; Xu S; Ma S; Chen Z Oncol Lett; 2015 Apr; 9(4):1681-1686. PubMed ID: 25789023 [TBL] [Abstract][Full Text] [Related]
15. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis. Bari R; Zhang YH; Zhang F; Wang NX; Stipp CS; Zheng JJ; Zhang XA Am J Pathol; 2009 Feb; 174(2):647-60. PubMed ID: 19116362 [TBL] [Abstract][Full Text] [Related]
16. Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization. Liu WM; Zhang F; Moshiach S; Zhou B; Huang C; Srinivasan K; Khurana S; Zheng Y; Lahti JM; Zhang XA PLoS One; 2012; 7(12):e51797. PubMed ID: 23251627 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer. Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175 [TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82. Dodla P; Bhoopalan V; Khoo SK; Miranti C; Sridhar S BMC Cancer; 2020 Dec; 20(1):1211. PubMed ID: 33298014 [TBL] [Abstract][Full Text] [Related]
19. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma. Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of KAI1/CD82 suppresses in vitro cell growth, migration, invasion and xenograft growth in oral cancer. Chai J; Du L; Ju J; Ma C; Shen Z; Yang X; Liang L; Ni Q; Sun M Mol Med Rep; 2017 Apr; 15(4):1527-1532. PubMed ID: 28260006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]